Darija Cör Andrejč
Željko Knez
Maša Knez Marevci- 1Faculty of Chemistry and Chemical Engineering, Maribor, Slovenia
- 2Laboratory Faculty of Medicine, Maribor, Slovenia
Ganoderma lucidum is a very medicinal mushroom that has been utilized in Oriental medicine for many years. It has a wide range of pharmacological and therapeutic properties, and has been used for many years as a health promoter. It contains various biologically active compounds that improve the immune system and have antioxidant, antitumor, anti-inflammatory, antifungal, and antimicrobial properties. Active compounds include triterpenoids and polysaccharides, as well as proteins, lipids, phenolics, sterols, etc. In the following review, we summarize briefly their biological activities, such as antioxidant, anti-bacterial, anti-fungal, antitumor, anti-viral, and anti-inflammatory activity. Although Ganoderma has a number of medicinal effects that have been confirmed by the in vitro and in vivo studies summarised in this review, there are some limitations. Clinical trials face mainly a lack of pure constituents. Accurate identification of the compounds obtained is also problematic. In addition, most of the included studies were small, and there were concerns about the methodological quality of each study. Studies have shown that Ganoderma has valuable potential for the prevention and treatment of cancer. In any case, G. lucidum cannot be used as first-line therapy for cancer.
Introduction
Nutraceuticals, or functional foods, contain bioactive compounds isolated from natural tissues that promote a wide range of activities in addition to their nutritional value. Extracts from medicinal mushrooms are used traditionally in traditional Chinese medicine for many years. The fruiting body, spores and mycelium of medicinal mushrooms contain many bioactive components, from which the medicinal properties are derived (Seweryn et al., 2021). One of these mushrooms is Ganoderma lucidum, which was discovered over 2,400 years ago, and is known to promote health, longevity, and mental growth. It is also recognized as a powerful immune booster, providing strong protection for the whole body (Wang J. et al., 2014). The substances found in the mushroom include triterpenoids, polysaccharides, nucleotides, sterols, steroids, fatty acids and proteins/peptides, and have numerous medicinal effects (Sanodiya et al., 2009; Sindhu et al., 2021). The main pharmacologically active compounds from G. lucidum are triterpenoids and polysaccharides. It has been found out that its bioactive compounds indicate antimicrobial (Karwa and Rai, 2012), antitumor (Sliva, 2003; Zhang et al., 2003; Kao et al., 2013), anti-inflammatory (Hasnat et al., 2015; Wen et al., 2022), hypolipidemic (Chen et al., 2005), antiatherosclerotic (Lai et al., 2020), anti-fungal, and anti-viral activity (Akbar and Yam, 2011; AL-jumaili et al., 2020; Cheng et al., 2021).
Several years of studies have confirmed that G. lucidum is an immunostimulant and a strong antioxidant. It can now be used as an adjunct to prevent the effects of chemotherapy and to tackle cancer (Jin et al., 2012). The different bioactive activities of triterpenoids and polysaccharides are shown in Figure 1. The polysaccharides of (GLPs) have many biological activities like: immunomodulatory, antineurodegenerative, antidiabetic, anti-inflammatory, anticancer, and antibacterial. In particular, β-d-glucans are well known to have biological and physiological activities (Wang X. M. et al., 2014).
FIGURE 1. Bioactive activities of triterpenoids and polysaccharides.
Triterpenoids possess antihypertensive, hypocholesterolemic, hepatoprotective and antihistaminic effects, as well as antitumor and antiangiogenic activity. Over a hundred of triterpenoid compounds have been found in extracts of G. lucidum. They are divided into Ganoderma acids (GA) or Ganoderma alcohols (GAlc). Various triterpenoids contain large amounts of lucidenoic acids (Bharadwaj et al., 2019).
Polysaccharides and triterpenoids from G. lucidum
Many natural biological polysaccharides have been shown to be good antioxidants. These include the polysaccharides of G. lucidum (GLPs). To date, a number of polysaccharides have been isolated from G. lucidum. The most abundant of these are β-D-glucans, α-D-glucans, α-D-mannans and polysaccharide-protein complexes. The type of extraction method depends on the structure of the cell wall, although hot water is the most frequently used media for extraction of these compounds (Siwulski et al., 2015).
The polysaccharide chains are stabilized by hydrogen bonds, and can form the tertiary structure of the triple helix. Such tertiary structures of the triple helix have also been confirmed in β-D-glucans of G. lucidum (Synytsya and Novák, 2013). The chemical structure of polysaccharides depends on the isolation method and the type of growth medium used. Crude polysaccharides contain impurities like proteins. This limits their use severely in medical and food applications, while proteins in combination with polysaccharides can trigger allergic reactions. For this reason, so-called deproteinization is used to obtain polysaccharides from natural biomass (Zeng et al., 2019).
Pure β-glucans are the main isolated compound from the G. lucidum fruiting body. However, heterofucans, heteromannans and their complexes with peptides, are also found (Sohretoglu and Huang, 2018). Low-molecular-weight polysaccharides GLP-1, which is a pure glucose polysaccharide, and GLP-2, which is composed of β-D-glucose and α-D-galactose, have been studied widely (Liu et al., 2010). Many methods are known to be used for the purification of polysaccharides, such as: trichloroacetic acid (TCA) precipitation (Fic et al., 2010), the enzymatic method (Wang et al., 2007, 31461), lead acetate precipitation (Chen et al., 2012), the Sevag method (Qin et al., 2002), salting out (Huang et al., 2012). With the Sevag method, a high proportion of polysaccharides are lost due to the harsh chemical treatment. In the case of lead acetate precipitation, heavy metal contamination is difficult to avoid. Salt precipitation is very often used for protein precipitation. TCA precipitation provides an operationally simple and efficient protein precipitation process. The enzymatic method is also a simple, environmentally friendly, efficient and inexpensive way to purify polysaccharides. Therefore, these three methods are the most used to produce deproteinized GLP. As mentioned above, the antioxidant activity of polysaccharides depends on their structure. The molecular weight, monosaccharide composition and chain conformation of polysaccharide are highly correlated with antioxidant activity (Zeng et al., 2019). During the processing steps, the primary structure of the polysaccharides can be destroyed, thus reducing the yield of the polysaccharides, as well as their antioxidant activity (Zeng et al., 2019).
Besides polysaccharides, G. lucidum contains triterpenoids, a subtype of terpenes, which are widely distributed in the plant. Their basic skeleton is C30, with molecular masses between 400 and 600 kDa. Their chemical structure is complex and highly oxidized. As they are pharmaceutically active compounds, they contribute to the biological capacity of G. lucidum. A large variety of triterpenoids, mostly ganoderic acids (GAs) (Yuen and Gohel, 2005; Shi et al., 2010), have been shown to be involved in several biological effects, including anti-inflammatory (Akihisa et al., 2007), anti-tumor (Li et al., 2013), anti-HIV (El-Mekkawy et al., 1998) and hypolipidemic activities. Ganoderic acids show an amphipathic effect on platelet aggregation. To date, more than a hundred triterpenes have been identified in G. lucidum (Yue et al., 2010), which also showed to have a number of enzymatic inhibitory effects (Sharma et al., 2019). Structural formula of β-1,3-glucan and ganoderic acid are presented in Figure 2. Structure of the most common ganoderic acids are presented on Figure 3.
FIGURE 2. G. lucidum β-1,3-glucan and ganoderic acid.
FIGURE 3. Structural formula of common Ganoderic acids found in Ganoderma lucidum.
Biological activities
Antioxidant activity
Various in vitro antioxidant assays confirmed the antioxidant potential of polysaccharides and polysaccharide complexes extracted from G. lucidum (Bukhman et al., 2007). Large amounts of free radicals cause a redox imbalance in the body, leading to oxidative damage in the tissues. Damage to proteins, lipids and DNA caused by oxidative stress is a significant factor in the development and progression of diseases. Polysaccharides isolated from G. lucidum exhibit antioxidant activity and protect tissues from reactive oxygen species toxicity. Moreover, they help sustain the oxidative state of the body (Jeong and Park, 2020).
The molar mass of polysaccharides is very important, because it is also related to the biological properties of the polysaccharide. The number of reductive ends of the hydroxyl group that can absorb and scavenge free radicals is crucial. Due to this, polysaccharides with a low molecular weight can indicate a higher antioxidant capacity (Ning et al., 2003). For example, a polysaccharide with low molecular weight demonstrated higher capacity in scavenging free radicals and chelating Fe(II). The reason for the better activity could be the molar mass (Liu et al., 2010).
There are numerous studies on the antioxidant activity of polysaccharides. Fan et al. reported that one of the factors affecting the antioxidant activity of polysaccharides is drying. They showed that. compared to other types of drying, the samples dried by hot air, vacuum and lyophilization demonstrated stronger antioxidant activity (Fan et al., 2012).
The polysaccharides also showed some antioxidant effect in in vitro studies. They were able to increase the activities of antioxidant enzymes (SOD, CAT, and GPx). They lower the levels of IL -1β, IL -6, and TNF-α in rats with cervical cancer (XiaoPing et al., 2009).
Yan et al. (2019) performed extraction of G. lucidum polysaccharides using electrolytically oxidized water. Compared with the conventional extraction method, the electrolytically oxidized water is an environmentally friendly and economically achievable technique. Polysaccharides prepared in this way showed strong antioxidant activity.
Kao et al. (2012) obtained β-1,3-glucan of high purity. The study of its biofunctions show actions against H2O2-induced apoptosis. Consequently, it is able to exert antioxidant effects by inhibiting SMases.
The most abundant GLP is formed from several amino acids. Sugars are connected by β-glycosidic bonds. GLP has been shown to improve non-enzymatic and enzymatic antioxidants, serum insulin levels and lipid peroxidation. In addition, high antioxidant activity has been demonstrated in vitro and in vivo (Jiang et al., 2012).
Li J. et al. (2020) demonstrated that GLPs increased white blood cell and lymphocyte amounts. Serum levels of IgG and IgA immunoglobulins were also examined, and higher IgA levels were observed.
Xu et al. (2019) investigated natural polysaccharides (GLP) and degraded polysaccharides by the ultrasonic method (GLPUD) and evaluated their hypolipidemic and antioxidant activities. GLPs have shown biological activity on superoxide dismutase and glutathione peroxidase. Malondialdehyde levels were heightened in the serum and liver of mice fed a high-fat diet. From this point of view, GLP can be considered as a new agent for the treatment of hyperlipidemia . Adeyi et al. (2021) also reported incredible biological effects, characterized by the in vitro and in vivo antioxidant activities of GLP extracts.
Biochemical transformations produce free oxygen and nitrogen radicals. These are highly reactive and cause mitochondrial disorders. Oxidative stress promotes the aging process and is associated with many neurodegenerative diseases, metabolic syndromes, and tumors. The antioxidant activity of polysaccharides does not depend on a single factor, but is a combination of several factors. This requires clarification of the structure, confirmation, and mechanisms affecting antioxidant activity. Further studies should focus on evaluating the degree of toxicity and assessing its potential efficacy in clinical trials.
In addition to polysaccharides, the triterpenoids of G. lucidum also exhibit antioxidant activity. To determine the antioxidant activity of triterpenoids extracted from G. lucidum, Dong et al. (2019) used the ability to scavenge two radicals, DPPH and ABTS. Wang et al. isolated some triterpenoids. Two of them, Lingzhin E and Lingzhin F, exhibited antioxidant activity by the ABTS method Zheng et al. (2020) used ethanol maceration to extract the triterpenoids and evaluated their antioxidant activity using the DPPH method, which depends on the concentration of terpenoids.
Zhu et al. (1999) mentioned that the fraction with terpenes consisted of ganoderic acids A, B, C, and D, lucidic acid B and ganodermanontriol as the main compounds, and were noted to have the strongest antioxidant effect.
Joseph et al. (2009) performed chloroform extraction of G. lucidum. The extract showed important antioxidant activity and lipid peroxidation inhibitory activity. In addition, methanolic extracts of G. lucidum were found to stop kidney damage by restoring the antioxidant protection system of the kidneys (Sheena et al., 2003b). All studies suggest that the antioxidant activities of G. lucidum may play an important role in inhibiting lipid peroxidation in biological systems.
Antibacterial activity
Terpenes, lectins, polysaccharides, etc., are considered antimicrobial compounds, and act on the bacterial cytoplasmic membrane (Kalam et al., 2010). The compounds found in G. lucidum can inhibit both gram-positive and gram-negative bacteria. For instance, an aqueous extract of G. lucidum can inhibit 15 species of gram-positive and gram-negative bacteria.
It has been reported that some compounds, such as ganomycin and triterpenoids, have broad spectrum antibacterial activity (Shah et al., 2014). Culture fluids from G. lucidum show antibacterial activity against bacterial plant pathogens (Robles-Hernández et al., 2021).
The extracts from G. lucidum were tested using the sulforhodamine B staining method for antiproliferative activity and the microdilution plate method. The results revealed that all five extracts produced an effective zone of inhibition, with the best by a methanol extract against Escherichia coli and Pseudomonas aeruginosa (Radhika, 2021). Sknepnek et al. (2018) prepared a G. lucidum hot water extract which was used for novel, health-promoting kombucha products. The liquid G. lucidum beverage showed inhibitory activity against Staphylococcus epidermidis, Rhodococcus equi, Bacillus spizizenii, B. cereus, and R. equi.
Moreover, peptides isolated from G. lucidum showed increased antibacterial activity against Escherichia coli and Salmonella typhi. This is probably due to two mechanisms: Inhibitory action and formation of reactive oxygen species, and the induction of intracellular protein leakage in bacterial cells (Mishra et al., 2018). Ergosta-5,7,22-triene-3β,14α-diol (22Z) was isolated from G. lucidum. It was proven that the component exhibited significant activity against Methicillin-Resistance Staphylococcus aureus (MRSA) and Streptococcus pyogenes (Sande et al., 2020).
The researchers investigated various extracts of G. lucidum, such as methanolic, chloroform, acetone and aqueous extracts, and observed antibacterial activity against different bacteria, such as Bacillus subtilis, Staphylococcus aureus, Enterobacter aerogenes, Corynebacterium diphtheria, Escherichia coli, Salmonella sp., and Pseudomonas aeruginosa (Kalam et al., 2010; Singh et al., 2014; Goud et al., 2019; Radhika, 2021). Furthermore, studies by Heleno et al. (2013) showed that some of the G. lucidum extracts indicate a higher antimicrobial activity than antibiotics such as streptomycin and penicillin. All these studies suggest that G. lucidum inhibits the development of various bacterial diseases.
Antifungal activity
There are very few publications on the antifungal activity of G. lucidum. Wang and Ng (2006) isolated the so-called ganodermin antifungal protein antifungal protein successfully, which inhibits the mycelial growth of Botrytis cinerea, Fusarium oxysporum, and Physalospora piricola.
Methanolic and aqueous extracts were examined against Penicillium sps., Aspergillus Fumigatous, Aspergillus niger, Aspergillus flavus, and Mucor indicus. Strong activity against Mucor indicus was observed (Sridhar et al., 2011). In the study by Heleno et al. (2013), an extract from G. lucidum exceeded the antifungal activity against Trichoderma viride, compared to the activity of known Standards, i.e., bifonazole and ketoconazole. Yang et al. (2022) reported that the combination of Ganoderma polysaccharides and small amounts of chemical fungicides was found to be effective in controlling wheat brood, root rot, and corn stalk rot successfully in continuous wheat growing areas.
Antitumor activity
A tumor needs a constant supply of nutrients to survive. Invasive cancer cells are spread by blood and lymph vessels. Therefore, agents must be used that can inhibit angiogenesis. Metastasis can also be controlled by targeting factors such as cell adhesion, invasion and migration. Chemotherapy inhibits angiogenesis, which means that it reduces the formation of blood vessels that supply the tumor , thereby reducing its nutrient supply (Sharma et al., 2019). Polysaccharides and triterpenes from G. lucidum have been shown to have chemopreventive and antitumor activity.
Studies indicate that different extracts or isolated compounds from G. lucidum act as a carcinostatic on different cancer cell lines, such as, lung (Li et al., 2013), colon (Li P. et al., 2020), pancreas (Chen et al., 2022), liver (Li et al., 2005), breast (Barbieri et al., 2017; Jiao et al., 2020), skin (Shahid et al., 2022), prostate (Wang et al., 2020). Ganoderic acids (GAs) -Mk, -S, -Mf, -R, -Mc, -T showed activities against the two tumor cell lines metastatic lung tumor cell line 95-D and human cervical cancer cell line HeLa (Li et al., 2013). GA—H and GA—A suppress the growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling (Jiang et al., 2008). It is obvious that the ganoderic acids are the compounds that play a key role in the biological activity of triterpenes. Some of the ganoderic acids and lucidenic acids, with their effects on tumor cells, are listed in Table 1.
TABLE 1. Triterpenoids with antitumor action on different cell lines.
Triterpenes also cause cell cycle arrest. They first downregulate cyclin D1 in the G1 phase of cell growth, and then inhibit PKC activity in the G2 growth phase. They also induce apoptosis in cancer cell lines. Furthermore, they prevent tumor metastasis by modulating MMPs and IL-8, and inhibit the excretion of inflammatory cytokines (Shahid et al., 2022).
On the other hand, there are Ganoderma polysaccharides (GLPs) which have the ability to boost the host’s immune response by stimulating macrophages, NK cells and T lymphocytes (Pan et al., 2013). Pan et al. isolated GLPs that enhance the anti-tumor immune response by stimulating the activity of natural killer cells and cytotoxic T lymphocytes (Pan et al., 2013). Sun et al. tested polysaccharides for lymphocyte activation. The polysaccharides were incubated with a tumor cell line that lacked antigen presentation. They showed that polysaccharides can stimulate melanoma cells to proliferate lymphocytes (Sun et al., 2011). β-glucan from G. lucidum showed considerable inhibition of the S180 tumor growth in mice in vivo (Fu et al., 2019). According to the studies by Wiater et al. (2012), α-D-glucans exhibit cytotoxic action in relation to human epithelial—HeLa cancer cells. Several in vivo studies have shown that polysaccharides exhibit antitumor activity against sarcoma180 in mice (Ferreira et al., 2015). Suarez-Arroyo et al. (2013) used G. lucidum as a potential therapeutic agent for inflammatory breast cancer (IBC) using in vivo and in vitro IBC models. G. lucidum has been shown to suppress protein synthesis and tumor growth by affecting signaling pathways for survival and proliferation. A study by Yu et al. (2018) showed that GLPs can activate macrophage cells, increase phagocytosis of macrophages in a dose-dependent manner, and ultimately inhibit the growth of human breast cancer cells. The results of Chen et al. showed that GLPs can stimulate the inflammatory response through the expression of IL -1, IL -6, and TNF-α, which is important for anti-tumor activity (Chen et al., 2004). All these studies prove that the components contained in Ganoderma have high antitumor activity.
Antiviral activity
The results of several studies suggest that G. lucidum is a potential candidate for the development of various antiviral agents (Eo et al., 1999). The genomic sequencing indicated that G. lucidum could fight against many viruses, such as herpes, influenza, EpsteinBarr, and hepatitis, including the very virulent and dangerous HINI strain of flu.
Lu et al. (2019) investigated the effect of liposomes (Lip) encapsulated with GLP on the inactivation of porcine circovirus type 2, or PCV2. It was found that Lip-GLP can increase the ratio of CD4+ to CD8+ T cells, enhance the response of PCV2 and stimulate cytokine secretion in mouse serum. Therefore, Lip-GLP is a promising formulation for stimulating immune responses against PCV-II (Liu et al., 2019).
It is known that a dengue virus (DENV) infection leads to serious health problems. The researchers used a computer-generated screening approach to predict triterpenoids from G. lucidum as potential inhibitors of DENV NS2B-NS3 protease. Ganodermanotriol was discovered to be the most promising compound against virus infection (Bharadwaj et al., 2019).
Enterovirus 71 (EV71) is a major cause of hand, foot, and mouth disease (HFMD), and lethal neurological and systemic complications in children. Zhang et al. evaluated the antiviral activities of some triterpenoids against enterovirus 71 infection. Some tested triterpenoids have been found to prevent virus infection by blocking virus adsorption to cells (Zhang et al., 2014).
Protein bound polysaccharides were isolated from a water soluble matrix of G. lucidum and showed antiviral activities against the herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) (Eo et al., 2000). Water-soluble and methanol-soluble components from G. lucidum showed in vitro activities against pathogenic viruses such as herpes simplex virus type 1 (HSV-1) and 2 (HSV-2), influenza A virus (Flu A), and vesicular stomatitis virus (VSV). Some compounds notably inhibited the cytopathic effects of HSV and VSV (Eo et al., 2000).
Some isolated compounds, ganoderic acid beta, lucidumol B, ganodermanondiol, ganodermanontriol, and ganolucidic acid A from G. lucidum, have been reported to have inhibitory effects on human immunodeficiency virus (HIV)-1 protease activity (El-Mekkawy et al., 1998; Min et al., 1998). Extensive research is still needed to lay the groundwork for the use of G. lucidum isolates as anti-HIV agents. Nevertheless, the triterpenoids appear to be the most important compound with anti-HIV activity (Gao et al., 2003; Cheng et al., 2021).
Ganoderic acid indicates inhibitory effects on the replication of the hepatitis B virus (HBV) (Wachtel-Galor et al., 2011). To date, antiviral potency has been confirmed with several ganoderic acids (GAs) that include GA-A, GA-B, GA-C1, GA-C2, GA-β, GA-T, GA-Q, GA-H, Ganoderol A, Ganoderol B, ganodermanondiol, and ganodermanontriol (Sharma et al., 2019).
The recent outbreak of a new coronavirus (SARS-CoV)-2 is currently a serious global public health threat. Despite the lack of clinical data, there is convincing evidence in the literature that certain nutraceuticals (triterpenoids, polysaccharides, nucleotides, sterols, steroids, fatty acids, and proteins/peptides) found in G. lucidum may be useful for the treatment of COVID -19 (Hetland et al., 2021). Results from AL-jumaili et al. (2020) indicate the increase in lymphocytes in G. lucidum supplemented to patients with COVID-19. β-glucans boost PRRs signals. As a result, protective inflammatory responses are developed that prevent infections by pathogens, including infection with coronaviruses. Therefore, G. lucidum can be used to help in the treatment of COVID-19 infections. Triterpene glycosides, which are present in several plants, including G. lucidum, inhibited the early stage human coronavirus 229E infection significantly by impairing viral replication, absorption, and penetration (Cheng et al., 2006). Ganoderma shows good antiviral potential against DENV and EV71. It also has an inhibitory effect on the protease activity of human immunodeficiency virus (HIV)-1. It is also a promising antiviral agent in COVID -19 infections.
Anti-inflammatory
A study by Hasnat et al. (2015) demonstrated that G. lucidum grown on germinated brown rice showed potential anti-inflammatory effects. Moreover, these results also indicate that GLBR reduces the severity of colitis drastically.
The anti-inflammatory activities of GLPs was determined by carrageenan-induced edema and formalin-induced edema inflammation assays. Results show that polysaccharide inhibited acute inflammation induced by carrageenan and chronic inflammation induced by formalin successfully (Joseph et al., 2011). Similar results were reported by Sheena et al. (2003a), where ethyl acetate and methanol extracts showed significant anti-inflammatory activity in acute and chronic inflammatory models in mice.
Extracts of G. lucidum exhibit excellent anti-inflammatory activity due to significant suppression of cytokines: IL -6, IL -23p19, immunomodulatory molecules: S100A7, S100A8, S100A9, and chemokines: CXCL8, CCL5, and CCL20 (Dudhgaonkar et al., 2009). Zhang et al. (2018) investigated the anti-inflammatory properties of sulfated polysaccharides prepared by chemical sulfation. The results showed that the polysaccharide could not only inhibit L-s-electin-mediated inflammation, but also inhibit the whole system.
Su et al. (2020) isolated eight undescribed lanostane triterpenoids from which ganoluciduone B exhibited moderate inhibitory activity on nitric oxide production. All these studies show that extracts of G. lucidum have favorable potential as anti-inflammatory agents.
Neuro-protective activity
Alzheimer’s disease (AD) is a very common chronic progressive neurodegenerative disease. There exists no effective treatment for this illness. Current treatments for Alzheimer’s are focused mainly on improving cognition and relieving symptoms. One of the approaches for treating AD is to control levels of the neurotransmitter acetylcholine in the brain through the inhibition of acetylcholinesterase (AChE). The treatments involve mostly drug therapy, which reduces the symptoms, but is accompanied by many side effects. Alternative treatments involving the use of compounds from G. lucidum have been shown to be useful in the treatment of AD (Qin et al., 2019). Zhang et al. (2011) reported that a mixture of triterpenoid compounds stimulates neuronal viability and reduces fatigue. In addition, research has shown that long-term consumption of G. lucidum as an adjuvant in the treatment of neurological disorders may reduce the progression of Alzheimer’s disease.
In the study by Rahman et al. (2020) rats were tested for memory and learning for six consecutive days. Rats fed with G. lucidum water extract needed less time to search items and used the shorter route. This means that their spatial perception and memory improved. Authors also reported the inhibition of acetylcholinesterase (AChE) of G. lucidum extracts from 22.5% to 50% (Hasnat et al., 2013; Cör et al., 2014). Lai et al. (2019) described that those alcoholic extracts from G. lucidum affect DNA methyltransferases by regulating DNA methylation. This may be an important signaling pathway influenced by G. lucidum in inhibiting the progression of AD. This extract, including ganoderic acid and lucidone A, may contribute to inhibiting the progression of AD. Aromatic compounds, including meroterpenoids and alkaloids, were investigated for their neuroprotective activity against CORT -induced PC12 cell damage. Their structures were determined by spectroscopic methods. The compounds showed remarkable neuroprotective activities against corticosterone-induced PC12 cell damage, and exhibited significant anti-inflammatory activities against LPS-induced nitric oxide production (NO) in RAW264.7 macrophages (Lu et al., 2019). From this point of view, G. lucidum appears to be promising in preventing the pathogenesis of Alzheimer’s disease caused by hypercholesterolemia.
Methods for extracting biologically active substances from G. lucidum
As mentioned above, a number of polysaccharides have been extracted and isolated from Ganoderma that have different chemical structures and have been shown to possess bioactive properties. The choice of extraction method for polysaccharide extraction is very important. Depending on the type and water solubility of the polysaccharide, the method of extraction is chosen. Usually, the cell wall is split from the outer to the inner part. Most polysaccharides can be extracted with hot water, acid saline, dilute alkaline solutions and dimethyl sulfoxide (Nie et al., 2013).
The most commonly used method for extracting polysaccharides from Ganoderma is hot water extraction. High temperatures are required to accelerate the dissolution of polysaccharides from cell walls. Usual extraction procedures are carried out by first defatting the base solids with organic solvents. This removes low molecular weight substances. Extraction is then carried out with hot water, saline solution and dilute alkaline solutions at different temperatures. Extraction with hot water is usually carried out for 3 h at 100°C. Hot water extraction is usually carried out at 100°C for 3 h, while 2% ammonium oxalate at 100°C for 6 h and 5% sodium hydroxide at 80°C for 6 h are used for extraction with saline and dilute alkaline solutions, respectively (Wang et al., 2011). Extraction with hot water yields water-soluble polysaccharides, while extraction with alkali yields water-insoluble polysaccharides (Nie et al., 2013). In addition to conventional extraction, various extraction methods such as microwave, ultrasonic, ultrasonic/microwave and enzyme extraction are also used for polysaccharide extraction, which can accelerate cell wall disruption and increase the yield of polysaccharides (Xu et al., 2007; Huang and Ning, 2010; Zhao et al., 2010; Ma et al., 2013; Kang et al., 2019). After extraction, the free proteins must be removed. The Sevag method is commonly used, in which the protein is precipitated after repeated denaturation by shaking with a solution of octanol in chloroform (Staub, 1965). To obtain crude polysaccharides the deproteinized solution is then precipitated with alcohol, methanol or acetone.
Since G. lucidum neutraceuticals are in high demand, the challenge is to increase the amount of bioactive compounds. The amount of active components in the mushroom is certainly influenced by the cultivation conditions (temperature, aeration, light, pH, humidity, growth media etc.) In the study by Sudheer et al. (2016b) the effect of ozone as an elicitor on the increase of bioactive compounds in the fungus is investigated. It was shown that the application of ozone doubles the bioactive compounds in the fungus and also increases the antioxidant activity of the extracts. Aeration and light also affect the growth and amount of bioactive compounds in the fungus. CO2 concentrations between 2%–5% stimulated the growth of antler-like fruiting bodies. Fungi growing under these conditions also showed higher biological activity (Sudheer et al., 2018). The growth medium is important for the development of the bioactive components of the fungus. Researchers also report the cultivation of G. lucidum on various types of sawdust, harrows, and especially on various agricultural wastes (Peksen and Yakupoglu, 2009; Gurung et al., 2012; Khoo et al., 2022). In one of the research been shown that the waste biomass of oil palm fibre the main agricurtural waste in Malaysia can be a good substrate for the growth of G. lucidum. Parameters such as temperature, pH, humidity, and the carbon and nitrogen composition required for optimal mycelial growth were studied and determined (Sudheer et al., 2016a). Chromatographic techniques such as ion exchange chromatography, gel filtration chromatography and affinity chromatography are most commonly used to obtain pure polysaccharides (Jiang et al., 2012).
The lanostane-type triterpenoids isolated from G. lucidum can be categorized as Ganoderma alcohols because of the hydroxyl group on the lanostane part or as Ganoderma acids because of the carboxyl group on the side chain. Triterpenoids can be extracted from Ganoderma with organic solvents or aqueous solutions. Pure triterpenoids are obtained with organic solvents, while aqueous mixtures yield triterpenoids that may also contain polysaccharides. Various methods are used to extract triterpenoids, such as microwave extraction, ultrasonic extraction, Soxhlet extraction, solvent extraction at elevated temperature etc. (Chen et al., 2007; Taofiq et al., 2017; Oludemi et al., 2018). The aim is to break the cell walls and gain access to the pharmacological active ingredients. However, extraction with hazardous organic solvents is harmful. For this reason, there is a growing trend toward the use of environmentally friendly technologies that avoid the use of hazardous organic solvents. One such technology is supercritical extraction. Dat et al. (2022) used supercritical CO2 to extract triterpenoids from Ganoderma. They demonstrated the cytotoxic effect of G. lucidum extract on cancer cells kb, HepG2, Lu, and MCF7 which indicate the potential of G. lucidum extract as an anticancer agent. Extensive laboratory and preclinical studies show that several purified triterpenes or triterpene-containing extracts of G. lucidum have a direct anticancer effect. For this reason, it is very important what technique is used, and in particular, what type of solvent is used to obtain a particular component. Therefore, it is necessary to consider the extraction of triterpenoids by more environmentally friendly extraction methods. Therefore, SC-CO2 extraction could be considered as an alternative and important method for the production of high quality compounds. Analytical methods for the characterisation and quantification of triterpenoids include: gas chromatography, liquid chromatography, thin-layer chromatography, supercritical fluid chromatography, NMR spectroscopy, capillary electrophoresis, and X-ray spectroscopy (Xu et al., 2018).
Discussion and future aspects
From the numerous studies that have been conducted and published, it can be summarised that G. lucidum may have various beneficial therapeutic properties. Extracts of Ganoderma have been reported to have antioxidant (Cherian et al., 2009; XiaoPing et al., 2009; Fan et al., 2012; Dong et al., 2019; Jeong and Park, 2020), antibacterial (Kalam et al., 2010; Heleno et al., 2013; Shah et al., 2014; Mishra et al., 2018; Sande et al., 2020), antifungal (Wang and Ng, 2006; Yang et al., 2022), antitumor (Sun et al., 2011; Li et al., 2013; Yu et al., 2018; Jiao et al., 2020; Shahid et al., 2022), antiviral (Eo et al., 2000; Wachtel-Galor et al., 2011; Zhang et al., 2014; AL-jumaili et al., 2020; Hetland et al., 2021), antiimflamatory activities, among others. These properties are attributed to numerous bioactive compounds such as triterpenes, polysaccharides, proteins and others.
Chemopreventive and therapeutic studies have shown how certain plant extracts act on various types of diseases, including cancer. G. lucidum is a very popular edible mushroom. It has been shown in numerous studies to modulate a number of signaling pathways responsible for the abnormal characteristics of cancer cells. Its effects are manifested in cell cycle slowing, induction of apoptosis, growth inhibition, and suppression of metastatic behaviour. Its action is shown by the inhibition of the constitutively active transcription factors NF-κB and AP -1, which have been mentioned as potential therapeutic targets for cancer therapy. Inhibition of NF-kb is extremely important for cancer prevention and treatment. Its function is to control the expression of proteins involved in cell adhesion, migration, and invasion (uPA, uPAR) (Jiang et al., 2008; Chen et al., 2010), proteins that protect against cell death (Bcl-2, BclXL) (Hsu et al., 2008), of oncoproteins that promote cell cycle dysregulation and tumorigenesis (cyclin D1) (Shahid et al., 2022), and of angiogenic factors that promote tumour growth (Hsu et al., 2009).
G. lucidum, in conjunction with its phenolic compounds, triterpenes, polysaccharides, and peptides, exhibits high antioxidant biological activity (Jiang et al., 2012; Kao et al., 2012; Dong et al., 2019; Jeong and Park, 2020; Zheng et al., 2020). Consumption of antioxidant-enriched foods has been shown to protect against cancer and other chronic diseases (Abdullah et al., 2012). However, this has not been explicitly demonstrated for antioxidants from G. lucidum. Therefore, further studies are needed to clarify the effect of antioxidants from Ganoderma on the host immune system. G. lucidum has also been described as a promising source of antimicrobial molecules, especially polysaccharides, against various viral (AL-jumaili et al., 2020; Cheng et al., 2021), bacterial (Radhika, 2021), and fungal pathogens (Wang and Ng, 2006; Yang et al., 2022). Scientific studies investigating antiviral activity have been conducted mainly on animals. Zhu et al. (2017) studied the anti-influenza effect of a hot aqueous extract of G. lucidum in infected mice, and the effect was very limited. Therefore, further studies are needed to confirm and improve the functional use of this fungus against influenza. The NS2B-NS3pro of dengue virus was recently identified as an ideal target for the development of new anti-dengue drugs. Ganodermanontriol from G. lucidum, a potent bioactive triterpenoid, has been reported to inhibit DENV-NS3pro based on in vitro studies. With further studies, ganodermanontriol could act as a drug against DENV virus (Bharadwaj et al., 2019). Furthermore, lanosta-7,9(11),24-trien-3-one, 15; 26-dihydroxy and ganoderic acid Y were also described as active against EV71 infections. Both compounds were shown to significantly inhibit viral RNA replication (vRNA) of EV71 by blocking EV71 uncoating. Therefore, both could be two promising agents to control and treat EV71 infections (Zhang et al., 2014). There is also an idea of using Ganoderma in the treatment of the new coronavirus. β-Glucans enhance PRR signaling. This develops protective inflammatory responses that prevent infections by pathogens, including infections by coronaviruses. Therefore, after further studies, G. lucidum can be used in the treatment of COVID -19 infections (AL-jumaili et al., 2020). In the field of neuroprotective effect. There are also studies that confirm that Ganoderma can have a positive influence on the development of Alzheimer’s disease (Zhang et al., 2011).
Much of the research on G. lucidum reports positive clinical results and potential therapeutic applications. For all this reason, G. lucidum and its derived products are still widely used as commercial products. However, despite its great importance, both the efficacy and safety of G. lucidum consumption have been insufficiently studied. Its safety and potential toxicity to humans have been poorly studied. One study reported that G. lucidum extracts may be toxic in vitro (Hapuarachchi et al., 2018). However, treatment with powdered G. lucidum spores even caused hepatotoxic effects (Wanmuang et al., 2007). Given the popularity of the mushroom, there is an urgent need for further research to gain a comprehensive understanding of its biomechanisms in addition to the numerous in vitro and in vivo studies already reported. And consequently, their biotherapeutic applicability. The methods used to isolate the active compounds from Ganoderma should also be considered. The polysaccharides are extracted mainly with hot water and the triterpenoids with organic solvents. However, it is obviously undesirable to extract the extracts with hazardous organic solvents. Therefore, scCO2 extraction is a promising method to obtain these compounds. To decipher the bioactive potency of these compounds, their proper isolation, purification, and identification is crucial. Further research is required to study the bioactive constituents of G. lucidum in detail. This will be useful for further use of these constituents in clinical trials and confirm or refute some of the study results.
Conclusion
The antioxidant, antimicrobial, antifungal, antitumor, antiviral, anti-inflammatory, and nevro-protective activities of the isolated compounds from G. lucidum were summarized in the present review. To date, studies on the bioactive activities of G. lucidum have focused on two groups of chemicals: triterpenoids and polysaccharides. Of the triterpenoids, ganoderic acids have been shown to be cytotoxic to a variety of cancer cell lines (breast, lung, liver, colon, etc.) and are therefore thought to be responsible for the antitumor activity. In addition to ganoderic acids, GLPs are also associated with antitumor activity, because they exhibit immunomodulatory activities. The properties of polysaccharides are probably related mainly to the molecular weight, degree of branching, and water solubility of polysaccharides. In the last three decades several GLPs have been extracted by different methods according to their structure. The most commonly isolated polysaccharides from G. lucidum are α- or β-(1→3)-, (1→6)-glucans and heteropolysaccharides with different sugar combinations.
A comprehensive understanding of the nutritional and therapeutic roles of G. lucidum extracts is essential for the development of new drugs and various functional foods. Further studies on the isolated compounds of G. lucidum are still needed, focusing on specific components of the bioactive compounds. These characterized components need to be evaluated by in vitro and in vivo studies to determine the exact amounts for further clinical studies. Since isolated compounds from G. lucidum have also been shown to be antiviral and immunomodulatory agents, this may also be a promising potential source for the current SARS-CoV-2 pandemic. Newly gained knowledge and further studies could facilitate the development of new nutraceuticals and pharmacological formulations from G. lucidum.
Author contributions
DC performed an extensive literature search and wrote most of the paper, MK and ŽK devised the content of the literature review and supervised the writing. All authors have read and agreed to the published version of the manuscript.
Funding
Financial support from the Slovenian Research Agency through Grant P2-0046 and Smart materials for bio applications J2-1725 and Advanced Extraction and Formulation of Functional Tannin Food Supplements with Beneficial Health Effectsis L2-3175 are acknowledged gratefully.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
CAT, catalase; CCL20, chemokine (C-C motif) ligand 20; CCL5, chemokine (C-C motif) ligand 5; CXCL8, C-X-C motif chemokine ligand 8; G-CSF, granulocyte colony stimulating factor; GM-CSF, myelopoietic growth factor and pro-inflammatory cytokine; GPX, glutathione peroxidase; IFN-γ, interferon-gamma; IL-1β, interleukin 1 beta; IL-6, interleukin 6; MAPK, mitogen-activated protein kinase; M-CSF, macrophage colony-stimulating factor; MDA-MB-231, human breast cancer cells; MT-1, of human breast malignant carcinoma cells; NM23-H1, Non-metastatic protein 23 H1; PKC, Protein kinase C; PRRs, pattern recognition receptors; S100A7, S100 calcium binding protein A7; S100A8, S100 calcium binding protein A8; S100A9, S100 calcium-binding protein A9; SMase, sphingomyelinase; SOD, superoxide dismutase; T cell, T lymphocyte; TNF-α, tumor necrosis factor alpha.
References
Abdullah, N., Ismail, S. M., Aminudin, N., Shuib, A. S., and Lau, B. F. (2012). Evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities. Evidence-Based Complementary and Alternative Medicine.
Adeyi, A. O., Awosanya, S. A., Adeyi, O. E., James, A. S., and Adenipekun, C. O. (2021). Ganoderma lucidum ethanol extract abrogates metabolic syndrome in rats: In vivo evaluation of hypoglycemic, hypolipidemic, hypotensive and antioxidant properties. Obes. Med. 22, 100320. doi:10.1016/j.obmed.2021.100320
Akbar, R., and Yam, W. K. (2011). Interaction of ganoderic acid on HIV related target: Molecular docking studies. Bioinformation 7, 413–417. doi:10.6026/97320630007413
Akihisa, T., Nakamura, Y., Tagata, M., Tokuda, H., Yasukawa, K., Uchiyama, E., et al. (2007). Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus ganoderma lucidum. Chem. Biodivers. 4, 224–231. doi:10.1002/cbdv.200790027
Al-jumaili, M. M. O., Al-dulaimi, F. K. Y., and Ajeel, M. A. (2020). The role of ganoderma lucidum uptake on some hematological and immunological response in patients with coronavirus (COVID-19). Syst. Rev. Pharm. 11, 5. doi:10.24926/iip.v11i2.3249
Barbieri, A., Quagliariello, V., Del Vecchio, V., Falco, M., Luciano, A., Amruthraj, N. J., et al. (2017). Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment. Nutrients 9, 210. doi:10.3390/nu9030210
Bharadwaj, S., Lee, K. E., Dwivedi, V. D., Yadava, U., Panwar, A., Lucas, S. J., et al. (2019). Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Sci. Rep. 9, 19059. doi:10.1038/s41598-019-55723-5
Bukhman, V. M., Treshchalina, E. M., Krasnopol'skaia, L. M., Isakova, E. B., Sedakova, L. A., Avtonomova, A. V., et al. (2007). Preparation and biological properties of basidiomycete aqueous extracts and their mycelial compositions. Antibiot. Khimioter 52, 4–9.
Chen, H. S., Tsai, Y. F., Lin, S., Lin, C. C., Khoo, K. H., Lin, C. H., et al. (2004). Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med. Chem. 12, 5595–5601. doi:10.1016/j.bmc.2004.08.003
Chen, H.-Y., Lei, J.-Y., Li, S.-L., Guo, L.-Q., Lin, J.-F., Wu, G.-H., et al. (2022). Progress in biological activities and biosynthesis of edible fungi terpenoids. Crit. Rev. Food Sci. Nutr. 10, 1–23. doi:10.1080/10408398.2022.2045559
Chen, N. H., Liu, J. W., and Zhong, J. J. (2008). Ganoderic acid me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J. Pharmacol. Sci. 108, 212–216. doi:10.1254/jphs.SC0080019
Chen, N. H., Liu, J. W., and Zhong, J. J. (2010). Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol. Rep. 62, 150–163. doi:10.1016/S1734-1140(10)70252-8
Chen, W. Q., Luo, S. H., Ll, H. Z., and Yang, H. (2005). Effects of ganoderma lucidum polysaccharides on serum lipids and lipoperoxidation in experimental hyperlipidemic rats. Zhongguo Zhong Yao Za Zhi 30, 1358–1360.
Chen, Y., Xie, M.-Y., and Gong, X.-F. (2007). Microwave-assisted extraction used for the isolation of total triterpenoid saponins from Ganoderma atrum. J. Food Eng. 81, 162–170. doi:10.1016/j.jfoodeng.2006.10.018
Chen, Y., Xie, M., Li, W., Zhang, H., Nie, S., Wang, Y., et al. (2012). An effective method for deproteinization of bioactive polysaccharides extracted from lingzhi (Ganoderma atrum). Food Sci. Biotechnol. 21, 191–198. doi:10.1007/s10068-012-0024-2
Cheng, P. G., Teoh, T. C., and Rizman-Idid, M. (2021). Chemical compounds and computational prediction of their inhibitory effects on the HIV-1 gp120 receptor by lingzhi or reishi medicinal mushroom, ganoderma lucidum (agaricomycetes), with antler-like morphology of fruiting bodies. Int. J. Med. Mushrooms 23, 63–77. doi:10.1615/IntJMedMushrooms.2021038682
Cheng, P. W., Ng, L. T., Chiang, L. C., and Lin, C. C. (2006). Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 33, 612–616. doi:10.1111/j.1440-1681.2006.04415.x
Cherian, E., Sudheesh, N. P., Janardhanan, K. K., and Patani, G. (2009). Free radical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (Curt: Fr) P. Karst and Arogyapacha-Trichopus zeylanicus Gaertn extracts. J. basic clinical physiol. pharmacol. 20, 289–308.
Cör, D., Botić, T., Knez, Ž., Batista, U., Gregori, A., Pohleven, F., et al. (2014). Two-stage extraction of antitumor, antioxidant and antiacetylcholinesterase compounds from Ganoderma lucidum fruiting body. J. Supercrit. Fluids 91, 53–60. doi:10.1016/j.supflu.2014.04.006
Dat, T. D., Viet, N. D., Thanh, V. H., Nhi, H. N. D., Linh, N. T. T., Ngan, N. T. K., et al. (2022). Optimization of triterpenoid extracted from Vietnamese ganoderma lucidum via supercritical extraction method and biological tests. Sep. Sci. Technol., 1–16. doi:10.1080/01496395.2022.2032750
Dong, Q., He, D., Ni, X., Zhou, H., and Yang, H. (2019). Comparative study on phenolic compounds, triterpenoids, and antioxidant activity of Ganoderma lucidum affected by different drying methods. Food Meas. 13, 3198–3205. doi:10.1007/s11694-019-00242-0
Dudhgaonkar, S., Thyagarajan, A., and Sliva, D. (2009). Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int. Immunopharmacol. 9, 1272–1280. doi:10.1016/j.intimp.2009.07.011
El-Mekkawy, S., Meselhy, M. R., Nakamura, N., Tezuka, Y., Hattori, M., Kakiuchi, N., et al. (1998). Anti-HIV-1 and anti-HIV-1-protease substances from ganoderma lucidum. Phytochemistry 49, 1651–1657. doi:10.1016/S0031-9422(98)00254-4
Eo, S.-K., Kim, Y.-S., Lee, C.-K., and Han, S.-S. (1999). Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J. Ethnopharmacol. 68, 129–136.
Eo, S. K., Kim, Y. S., Lee, C. K., and Han, S. S. (2000). Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J. Ethnopharmacol. 72, 475–481. doi:10.1016/S0378-8741(00)00266-X
Fan, L., Li, J., Deng, K., and Ai, L. (2012). Effects of drying methods on the antioxidant activities of polysaccharides extracted from Ganoderma lucidum. Carbohydrate Polymers 87, 1849–1854. doi:10.1016/j.carbpol.2011.10.018
Ferreira, I. C., Heleno, S. A., Reis, F. S., Stojkovic, D., Queiroz, M. J., Vasconcelos, M. H., et al. (2015). Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry 114, 38–55. doi:10.1016/j.phytochem.2014.10.011
Fic, E., Kedracka-Krok, S., Jankowska, U., Pirog, A., and Dziedzicka-Wasylewska, M. (2010). Comparison of protein precipitation methods for various rat brain structures prior to proteomic analysis. Electrophoresis 31, 3573–3579. doi:10.1002/elps.201000197
Fu, Y., Shi, L., and Ding, K. (2019). Structure elucidation and anti-tumor activity in vivo of a polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Int. J. Biol. Macromol. 141, 693–699. doi:10.1016/j.ijbiomac.2019.09.046
Gao, Y., Zhou, S., Jiang, W., Huang, M., and Dai, X. (2003). Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol. Invest. 32, 201–215. doi:10.1081/imm-120022979
Goud, N. S., Das, S. K., Ranjan, H., and Kumari, S. K. (2019). Antioxidant activity, antibacterial activity and total phenol and flavonoid analysis of Ganoderma lucidum. J. Glob. Trends Pharm. Sci. 10, 6894–6899.
Gurung, O. K., Budathoki, U., and Parajuli, G. (2012). Effect of different substrates on the production of ganoderma lucidum (curt.: Fr.) karst. Our Nat. 10, 191–198. doi:10.3126/on.v10i1.7781
Hapuarachchi, K. K., Elkhateeb, W. A., Karunarathna, S. C., Cheng, C. R., Bandara, A. R., Kakumyan, P., et al. (2018). Current status of global Ganoderma cultivation, products, industry and market. Mycosphere 9, 1025–1052.
Hasnat, A., Pervin, M., and Lim, B. O. (2013). Acetylcholinesterase inhibition and in vitro and in vivo antioxidant activities of ganoderma lucidum grown on germinated Brown rice. Molecules 18, 6663–6678. doi:10.3390/molecules18066663
Hasnat, M. A., Pervin, M., Cha, K. M., Kim, S. K., and Lim, B. O. (2015). Anti-inflammatory activity on mice of extract of Ganoderma lucidum grown on rice via modulation of MAPK and NF-κB pathways. Phytochemistry 114, 125–136. doi:10.1016/j.phytochem.2014.10.019
Heleno, S. A., Ferreira, I. C., Esteves, A. P., Ćirić, A., Glamočlija, J., Martins, A., et al. (2013). Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chem. Toxicol. 58, 95–100. doi:10.1016/j.fct.2013.04.025
Hetland, G., Johnson, E., Bernardshaw, S. V., and Grinde, B. (2021). Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation? Scand. J. Immunol. 93, e12937. doi:10.1111/sji.12937
Hsu, C. L., Yu, Y. S., and Yen, G. C. (2008). Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. J. Agric. Food Chem. 56, 3973–3980. doi:10.1021/jf800006u
Hsu, S.-C., Ou, C.-C., Chuang, T.-C., Li, J.-W., Lee, Y.-J., Wang, V., et al. (2009). Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Cancer Lett. 281, 108–116.
Huang, G., Shu, S., Cai, T., Liu, Y., and Xiao, F. (2012). Preparation and deproteinization of garlic polysaccharide. Int. J. Food Sci. Nutr. 63, 739–741. doi:10.3109/09637486.2011.652599
Huang, S. Q., and Ning, Z. X. (2010). Extraction of polysaccharide from Ganoderma lucidum and its immune enhancement activity. Int. J. Biol. Macromol. 47, 336–341. doi:10.1016/j.ijbiomac.2010.03.019
Jeong, Y. U., and Park, Y. J. (2020). Ergosterol peroxide from the medicinal mushroom ganoderma lucidum inhibits differentiation and lipid accumulation of 3T3-L1 adipocytes. Int. J. Mol. Sci. 21, 460. doi:10.3390/ijms21020460
Jiang, H., Sun, P., He, J., and Shao, P. (2012). Rapid purification of polysaccharides using novel radial flow ion-exchange by response surface methodology from Ganoderma lucidum. Food Bioprod. Process. 90, 1–8. doi:10.1016/j.fbp.2010.12.001
Jiang, J., Grieb, B., Thyagarajan, A., and Sliva, D. (2008). Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. Int. J. Mol. Med. 21, 577–584. doi:10.3892/ijmm.21.5.577
Jiao, C., Chen, W., Tan, X., Liang, H., Li, J., Yun, H., et al. (2020). Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. J. Ethnopharmacol. 247, 112256. doi:10.1016/j.jep.2019.112256
Jin, X., Beguerie, J. R., Sze, D. M., and Chan, G. C. (2012). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst. Rev. 6, 1–37. doi:10.1002/14651858.CD007731.pub2
Johnson, B. M., Doonan, B. P., Radwan, F. F., and Haque, A. (2010). Ganoderic acid DM: An alternative agent for the treatment of advanced prostate cancer. Open Prost. Cancer J. 3, 78–85. doi:10.2174/1876822901003010078
Joseph, S., Sabulal, B., George, V., Antony, K. R., and Janardhanan, K. K. (2011). Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 61, 335–342. doi:10.2478/v10007-011-0030-6
Joseph, S., Sabulal, B., George, V., Smina, T. P., and Janardhanan, K. K. (2009). Antioxidative and antiinflammatory activities of the chloroform extract of ganoderma lucidum found in south India. Sci. Pharm. 77, 111–121. doi:10.3797/scipharm.0808-17
Kalam, S., Pandey, A. K., and Sandhu, S. S. (2010). Evaluation of antibacterial activity of different Ganoderma lucidum extracts. J. Sci. Res. 3, 9–13.
Kang, Q., Chen, S., Li, S., Wang, B., Liu, X., Hao, L., et al. (2019). Comparison on characterization and antioxidant activity of polysaccharides from Ganoderma lucidum by ultrasound and conventional extraction. Int. J. Biol. Macromol. 124, 1137–1144. doi:10.1016/j.ijbiomac.2018.11.215
Kao, C., Jesuthasan, A. C., Bishop, K. S., Glucina, M. P., and Ferguson, L. R. (2013). Anti-cancer activities of ganoderma lucidum: Active ingredients and pathways. Funct. Foods Health Dis. 3, 48–65. doi:10.31989/ffhd.v3i2.65
Kao, P.-F., Wang, S.-H., Hung, W.-T., Liao, Y.-H., Lin, C.-M., and Yang, W.-B. (2012). Structural characterization and antioxidative activity of low-molecular-weights beta-1,3-glucan from the residue of ExtractedGanoderma lucidumFruiting bodies. J. Biomed. Biotechnol. 2012, 1–8. doi:10.1155/2012/673764
Karwa, A. S., and Rai, M. K. (2012). Naturally occurring medicinal mushroom-derived antimicrobials: A case-study using lingzhi or reishi Ganoderma lucidum (W. Curt.:Fr.) P. Karst. (Higher basidiomycetes). Int. J. Med. Mushr 14, 481–490. doi:10.1615/IntJMedMushr.v14.i5.60
Khoo, S. C., Ma, N. L., Peng, W. X., Ng, K. K., Goh, M. S., Chen, H. L., et al. (2022). Valorisation of biomass and diaper waste into a sustainable production of the medical mushroom Lingzhi Ganoderma lucidum. Chemosphere 286, 131477. doi:10.1016/j.chemosphere.2021.131477
Lai, G., Guo, Y., Chen, D., Tang, X., Shuai, O., Yong, T., et al. (2019). Alcohol extracts from ganoderma lucidum delay the progress of Alzheimer’s disease by regulating DNA methylation in rodents. Front. Pharmacol. 10, 272. doi:10.3389/fphar.2019.00272
Lai, P., Cao, X., Xu, Q., Liu, Y., Li, R., Zhang, J., et al. (2020). Ganoderma lucidum spore ethanol extract attenuates atherosclerosis by regulating lipid metabolism via upregulation of liver X receptor alpha. Pharm. Biol. 58, 760–770. doi:10.1080/13880209.2020.1798471
Li, C. H., Chen, P. Y., Chang, U. M., Kan, L. S., Fang, W. H., Tsai, K. S., et al. (2005). Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 77, 252–265. doi:10.1016/j.lfs.2004.09.045
Li, F., Wang, Y., Wang, X., Li, J., Cui, H., and Niu, M. (2012). Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells. Int. J. Clin. Pharmacol. Ther. 50, 712–721. doi:10.5414/CP201663
Li, J., Gu, F., Cai, C., Hu, M., Fan, L., Hao, J., et al. (2020). Purification, structural characterization, and immunomodulatory activity of the polysaccharides from Ganoderma lucidum. Int. J. Biol. Macromol. 143, 806–813. doi:10.1016/j.ijbiomac.2019.09.141
Li, P., Liu, L., Huang, S., Zhang, Y., Xu, J., and Zhang, Z. (2020). Anti-cancer effects of a neutral triterpene fraction from Ganoderma lucidum and its active constituents on SW620 human colorectal cancer cells. Anticancer Agents Med. Chem. 20, 237–244. doi:10.2174/1871520619666191015102442
Li, Y. B., Liu, R. M., and Zhong, J. J. (2013). A new ganoderic acid from Ganoderma lucidum mycelia and its stability. Fitoterapia 84, 115–122. doi:10.1016/j.fitote.2012.11.008
Liu, W., Wang, H., Pang, X., Yao, W., and Gao, X. (2010). Characterization and antioxidant activity of two low-molecular-weight polysaccharides purified from the fruiting bodies of Ganoderma lucidum. Int. J. Biol. Macromol. 46, 451–457. doi:10.1016/j.ijbiomac.2010.02.006
Liu, Z., Zhu, T., He, J., Zhang, Y., Gu, P., Qiu, T., et al. (2019). Adjuvanticity of Ganoderma lucidum polysaccharide liposomes on porcine circovirus type-II in mice. Int. J. Biol. Macromol. 141, 1158–1164. doi:10.1016/j.ijbiomac.2019.09.079
Lu, S. Y., Peng, X. R., Dong, J. R., Yan, H., Kong, Q. H., Shi, Q. Q., et al. (2019). Aromatic constituents from Ganoderma lucidum and their neuroprotective and anti-inflammatory activities. Fitoterapia 134, 58–64. doi:10.1016/j.fitote.2019.01.013
Ma, C.-w., Feng, M., Zhai, X., Hu, M., You, L., Luo, W., et al. (2013). Optimization for the extraction of polysaccharides from Ganoderma lucidum and their antioxidant and antiproliferative activities. J. Taiwan Inst. Chem. Eng. 44, 886–894. doi:10.1016/j.jtice.2013.01.032
Min, B. S., Nakamura, N., Miyashiro, H., Bae, K. W., and Hattori, M. (1998). Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. (Tokyo) 46, 1607–1612. doi:10.1248/cpb.46.1607
Mishra, J., Rajput, R., Singh, K., Puri, S., Goyal, M., Bansal, A., et al. (2018). Antibacterial natural peptide fractions from Indian ganoderma lucidum. Int. J. Pept. Res. Ther. 24, 543–554. doi:10.1007/s10989-017-9643-z
Nie, S., Zhang, H., Li, W., and Xie, M. (2013). Current development of polysaccharides from ganoderma: Isolation, structure and bioactivities. Bioact. Carbohydrates Diet. Fibre 1, 10–20. doi:10.1016/j.bcdf.2013.01.001
Ning, J., Zhang, W., Yi, Y., Yang, G., Wu, Z., Yi, J., et al. (2003). Synthesis of β-(1→6)-branched β-(1→3) glucohexaose and its analogues containing an α-(1→3) linked bond with antitumor activity. Bioorg. Med. Chem. 11, 2193–2203. doi:10.1016/s0968-0896(03)00118-4
Oludemi, T., Barros, L., Prieto, M. A., Heleno, S. A., Barreiro, M. F., and Ferreira, I. C. F. R. (2018). Extraction of triterpenoids and phenolic compounds from ganoderma lucidum: Optimization study using the response surface methodology. Food Funct. 9, 209–226. doi:10.1039/c7fo01601h
Pan, K., Jiang, Q., Liu, G., Miao, X., and Zhong, D. (2013). Optimization extraction of Ganoderma lucidum polysaccharides and its immunity and antioxidant activities. Int. J. Biol. Macromol. 55, 301–306. doi:10.1016/j.ijbiomac.2013.01.022
Peksen, A., and Yakupoglu, G. (2009). Tea waste as a supplement for the cultivation of Ganoderma lucidum. World J. Microbiol. Biotechnol. 25, 611–618. doi:10.1007/s11274-008-9931-z
Qin, C., Huang, K., and Xu, H. (2002). Isolation and characterization of a novel polysaccharide from the mucus of the loach, Misgurnus anguillicaudatus. Carbohydr. Polym. 49, 367–371. doi:10.1016/s0144-8617(01)00335-6
Qin, L. H., Wang, C., Qin, L. W., Liang, Y. F., and Wang, G. H. (2019). Spore powder of ganoderma lucidum for Alzheimer's disease: A protocol for systematic review. Med. Baltim. 98, e14382. doi:10.1097/MD.0000000000014382
Radhika, R. (2021). Antibacterial activity of ganoderma lucidum extracts against mdr pathogens. Int. J. Mod. Agric. 10, 3488–3493.
Rahman, M. A., Hossain, S., Abdullah, N., and Aminudin, N. (2020). Lingzhi or reishi medicinal mushroom, Ganoderma lucidum (agaricomycetes) ameliorates spatial learning and memory deficits in rats with hypercholesterolemia and Alzheimer’s disease. Int. J. Med. Mushrooms 22, 93–103. doi:10.1615/IntJMedMushrooms.2020033383
Robles-Hernández, L., Salas-Salazar, N. A., and Gonzalez-Franco, A. C. (2021). Purification and characterization of antibacterial activity against phytopathogenic bacteria in culture fluids from ganoderma lucidum. Molecules 26, 5553. doi:10.3390/molecules26185553
Sande, E., Baraza, D. L., Ooko, S., and Nyongesa, P. K. (2020). Isolation, characterization and antibacterial activity of ergosta-5, 7, 22-triene-3β, 14α – Diol (22Z) from Kenyan ganoderma lucidum. Asian J. Appl. Chem. Res. 5, 48–57. doi:10.9734/ajacr/2020/v5i130127
Sanodiya, B. S., Thakur, G. S., Baghel, R. K., Prasad, G. B., and Bisen, P. S. (2009). Ganoderma lucidum: A potent pharmacological macrofungus. Curr. Pharm. Biotechnol. 10, 717–742. doi:10.2174/138920109789978757
Seweryn, E., Ziała, A., and Gamian, A. (2021). Health-promoting of polysaccharides extracted from ganoderma lucidum. Nutrients 13, 2725. doi:10.3390/nu13082725
Shah, P., Modi, H. A., Shukla, M. D., and Lahiri, S. K. (2014). Preliminary phytochemical analysis and antibacterial activity of Ganoderma lucidum collected from Dang District of Gujarat, India. Int. J. Curr. Microbiol. App Sci. 3, 246–255.
Shahid, A., Huang, M., Liu, M., Shamim, M. A., Parsa, C., Orlando, R., et al. (2022). The medicinal mushroom Ganoderma lucidum attenuates UV-induced skin carcinogenesis and immunosuppression. Plos one 17, e0265615. doi:10.1371/journal.pone.0265615
Sharma, C., Bhardwaj, N., Sharma, A., Tuli, H. S., Batra, P., Beniwal, V., et al. (2019). Bioactive metabolites of Ganoderma lucidum: Factors, mechanism and broad spectrum therapeutic potential. J. Herb. Med. 17-18, 100268. doi:10.1016/j.hermed.2019.100268
Sheena, N., Ajith, T. A., and Janardhanan, K. K. (2003a). Anti-inflammatory and anti-nociceptive activities of ganoderma lucidum occurring in south India. Pharm. Biol. 41, 301–304. doi:10.1076/phbi.41.4.301.15677
Sheena, N., Ajith, T. A., and Janardhanan, K. K. (2003b). Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medicinal mushroom occurring in South India. Curr. Sci. 85, 478–482.
Shi, L., Ren, A., Mu, D., and Zhao, M. (2010). Current progress in the study on biosynthesis and regulation of ganoderic acids. Appl. Microbiol. Biotechnol. 88, 1243–1251. doi:10.1007/s00253-010-2871-1
Sindhu, R. K., Goyal, A., Das, J., Neha, S., Choden, S., and Kumar, P. (2021). Immunomodulatory potential of polysaccharides derived from plants and microbes: A narrative review. Carbohydr. Polym. Technol. Appl. 2, 100044. doi:10.1016/j.carpta.2021.100044
Singh, J., Gupta, S., Malviya, S., and Ahrwar, B. (2014). In-vitro evaluation of antimicrobial activity of Ganoderma lucidum. Int. J. Adv. Res. 2, 460–466.
Siwulski, M., Sobieralski, K., Golak-Siwulska, I., Sokół, S., and Sękara, A. (2015). Ganoderma lucidum (curt.: Fr.) karst. – Health-promoting properties. A review. Herba Pol. 61, 105–118. doi:10.1515/hepo-2015-0026
Sknepnek, A., Pantić, M., Matijašević, D., Miletić, D., Lević, S., Nedović, V., et al. (2018). Novel kombucha beverage from lingzhi or reishi medicinal mushroom, Ganoderma lucidum, with antibacterial and antioxidant effects. Int. J. Med. Mushrooms 20, 243–258. doi:10.1615/IntJMedMushrooms.2018025833
Sliva, D. (2003). Ganoderma lucidum (Reishi) in cancer treatment. Integr. Cancer Ther. 2, 358–364. doi:10.1177/1534735403259066
Sohretoglu, D., and Huang, S. (2018). Ganoderma lucidum polysaccharides as an anti-cancer agent. Anti-Cancer Agents Med. Chem. 18, 667–674. doi:10.2174/1871520617666171113121246
Sridhar, S., Sivaprakasam, E., Balakumar, R., and Kavitha, D. (2011). Evaluation of antibacterial and antifungal activity of Ganoderma lucidum (Curtis) P. Karst fruit bodies extracts. World J. Sci. Technol. 1, 08–11.
Su, H. G., Peng, X. R., Shi, Q. Q., Huang, Y. J., Zhou, L., and Qiu, M. H. (2020). Lanostane triterpenoids with anti-inflammatory activities from Ganoderma lucidum. Phytochemistry 173, 112256. doi:10.1016/j.phytochem.2019.112256
Suarez-Arroyo, I. J., Rosario-Acevedo, R., Aguilar-Perez, A., Clemente, P. L., Cubano, L. A., Serrano, J., et al. (2013). Anti-tumor effects of ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLOS ONE 8, e57431. doi:10.1371/journal.pone.0057431
Sudheer, S., Ali, A., and Manickam, S. (2016a). Investigation of requisites for the optimal mycelial growth of the lingzhi or reishi medicinal mushroom, ganoderma lucidum (agaricomycetes), on oil palm biomass in Malaysia. Int. J. Med. Mushrooms 18, 935–943. doi:10.1615/IntJMedMushrooms.v18.i10.90
Sudheer, S., Taha, Z., Manickam, S., Ali, A., and Cheng, P. G. (2018). Development of antler-type fruiting bodies of Ganoderma lucidum and determination of its biochemical properties. Fungal Biol. 122, 293–301. doi:10.1016/j.funbio.2018.01.007
Sudheer, S., Yeoh, W. K., Manickam, S., and Ali, A. (2016b). Effect of ozone gas as an elicitor to enhance the bioactive compounds in Ganoderma lucidum. Postharvest Biol. Technol. 117, 81–88. doi:10.1016/j.postharvbio.2016.01.014
Sun, L. X., Lin, Z. B., Li, X. J., Li, M., Lu, J., Duan, X. S., et al. (2011). Promoting effects of ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin. Pharmacol. Toxicol. 108, 149–154. doi:10.1111/j.1742-7843.2010.00632.x
Synytsya, A., and Novák, M. (2013). Structural diversity of fungal glucans. Carbohydr. Polym. 92, 792–809. doi:10.1016/j.carbpol.2012.09.077
Tang, W., Liu, J. W., Zhao, W. M., Wei, D. Z., and Zhong, J. J. (2006). Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci. 80, 205–211. doi:10.1016/j.lfs.2006.09.001
Taofiq, O., Heleno, S. A., Calhelha, R. C., Alves, M. J., Barros, L., González-Paramás, A. M., et al. (2017). The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits. Food Chem. Toxicol. 108, 139–147. doi:10.1016/j.fct.2017.07.051
Wachtel-Galor, S., Yuen, J., Buswell, J. A., and Benzie, I. F. F. (2011). “Ganoderma lucidum (lingzhi or reishi): A medicinal mushroom,” in Herbal medicine: Biomolecular and clinical aspects. Editors I. F. F. Benzie,, and S. Wachtel-Galor (Boca Raton (FL: CRC Press/Taylor & Francis). Available at: http://www.ncbi.nlm.nih.gov/books/NBK92757/(Accessed December 22, 2017).
Wang, H., and Ng, T. B. (2006). Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides 27, 27–30. doi:10.1016/j.peptides.2005.06.009
Wang, J., Yuan, Y., and Yue, T. (2014). Immunostimulatory activities of β-d-glucan from ganoderma lucidum. Carbohydr. Polym. 102, 47–54. doi:10.1016/j.carbpol.2013.10.087
Wang, J., Ma, Z., Zhang, L., Fang, Y., Jiang, F., and Phillips, G. O. (2011). Structure and chain conformation of water-soluble heteropolysaccharides from Ganoderma lucidum. Carbohydr. Polym. 86, 844–851. doi:10.1016/j.carbpol.2011.05.031
Wang, X., Wang, B., Zhou, L., Wang, X., Veeraraghavan, V. P., Mohan, S. K., et al. (2020). Ganoderma lucidum put forth anti-tumor activity against PC-3 prostate cancer cells via inhibition of Jak-1/STAT-3 activity. Saudi J. Biol. Sci. 27, 2632–2637. doi:10.1016/j.sjbs.2020.05.044
Wang, X., Yuan, Y., Wang, K., Zhang, D., Yang, Z., and Xu, P. (2007). Deproteinization of gellan gum produced by Sphingomonas paucimobilis ATCC 31461. J. Biotechnol. 128, 403–407. doi:10.1016/j.jbiotec.2006.09.019
Wang, X. M., Zhang, J., Wu, L. H., Zhao, Y. L., Li, T., Li, J. Q., et al. (2014). A mini-review of chemical composition and nutritional value of edible wild-grown mushroom from China. Food Chem. 151, 279–285. doi:10.1016/j.foodchem.2013.11.062
Wanmuang, H., Leopairut, J., Kositchaiwat, C., Wananukul, W., and Bunyaratvej, S. (2007). Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J. Medical Association Thailand 90, 179.
Wen, L., Sheng, Z., Wang, J., Jiang, Y., and Yang, B. (2022). Structure of water-soluble polysaccharides in spore of Ganoderma lucidum and their anti-inflammatory activity. Food Chem. 373, 131374. doi:10.1016/j.foodchem.2021.131374
Weng, C. J., Chau, C. F., Hsieh, Y. S., Yang, S. F., and Yen, G. C. (2008). Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29, 147–156. doi:10.1093/carcin/bgm261
Wiater, A., Paduch, R., Choma, A., Pleszczyńska, M., Siwulski, M., Dominik, J., et al. (2012). Biological study on carboxymethylated (1→3)-α-D-glucans from fruiting bodies of Ganoderma lucidum. Int. J. Biol. Macromol. 51, 1014–1023. doi:10.1016/j.ijbiomac.2012.08.017
XiaoPing, C., Yan, C., ShuiBing, L., YouGuo, C., JianYun, L., and LanPing, L. (2009). Free radical scavenging of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes and immunity activities in cervical carcinoma rats. Carbohydr. Polym. 77, 389–393. doi:10.1016/j.carbpol.2009.01.009
Xu, C., Wang, B., Pu, Y., Tao, J., and Zhang, T. (2018). Techniques for the analysis of pentacyclic triterpenoids in medicinal plants. J. Sep. Sci. 41, 6–19. doi:10.1002/jssc.201700201
Xu, G. F., Pang, X. B., and Gao, X. D. (2007). Microwave-assistant extraction of Ganoderma lucidum polysaccharide. Pharm. Clin. Res. 15, 297–299.
Xu, K., Liang, X., Gao, F., Zhong, J., and Liu, J. (2010). Antimetastatic effect of ganoderic acid T in vitro through inhibition of cancer cell invasion. Process Biochem. 45, 1261–1267. doi:10.1016/j.procbio.2010.04.013
Xu, Y., Zhang, X., Yan, X. H., Zhang, J. L., Wang, L. Y., Xue, H., et al. (2019). Characterization, hypolipidemic and antioxidant activities of degraded polysaccharides from Ganoderma lucidum. Int. J. Biol. Macromol. 135, 706–716. doi:10.1016/j.ijbiomac.2019.05.166
Yan, Z., Li, S., Yu, H., and Xin, X. (2019). Extraction and antioxidant activity of Ganoderma lucidum polysaccharides using electrolyzed oxidizing water. IOP Conf. Ser. Earth Environ. Sci. 252, 022074. doi:10.1088/1755-1315/252/2/022074
Yang, X., Sun, S., Chen, Q., Zhang, Z., Wang, J., Liu, Y., et al. (2022). A polysaccharide of ganoderma lucidum enhances antifungal activity of chemical fungicides against soil-borne diseases of wheat and maize by induced resistance. Agriculture 12, 55. doi:10.3390/agriculture12010055
Yu, Y., Shen, M., Song, Q., and Xie, J. (2018). Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review. Carbohydr. Polym. 183, 91–101. doi:10.1016/j.carbpol.2017.12.009
Yue, Q. X., Cao, Z. W., Guan, S. H., Liu, X. H., Tao, L., Wu, W. Y., et al. (2008). Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol. Cell Proteomics 7, 949–961. doi:10.1074/mcp.M700259-MCP200
Yue, Q. X., Song, X. Y., Ma, C., Feng, L. X., Guan, S. H., Wu, W. Y., et al. (2010). Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine 17, 606–613. doi:10.1016/j.phymed.2009.12.013
Yuen, J. W., and Gohel, M. D. (2005). Anticancer effects of ganoderma lucidum: A review of scientific evidence. Nutr. Cancer 53, 11–17. doi:10.1207/s15327914nc5301_2
Zeng, X., Li, P., Chen, X., Kang, Y., Xie, Y., Li, X., et al. (2019). Effects of deproteinization methods on primary structure and antioxidant activity of Ganoderma lucidum polysaccharides. Int. J. Biol. Macromol. 126, 867–876. doi:10.1016/j.ijbiomac.2018.12.222
Zhang, H. N., He, J. H., Yuan, L., and Lin, Z. B. (2003). In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci. 73, 2307–2319. doi:10.1016/S0024-3205(03)00594-0
Zhang, K., Liu, Y., Zhao, X., Tang, Q., Dernedde, J., Zhang, J., et al. (2018). Anti-inflammatory properties of GLPss58, a sulfated polysaccharide from Ganoderma lucidum. Int. J. Biol. Macromol. 107, 486–493. doi:10.1016/j.ijbiomac.2017.09.015
Zhang, W., Tao, J., Yang, X., Yang, Z., Zhang, L., Liu, H., et al. (2014). Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem. Biophys. Res. Commun. 449, 307–312. doi:10.1016/j.bbrc.2014.05.019
Zhang, X. Q., Ip, F. C., Zhang, D. M., Chen, L. X., Zhang, W., Li, Y. L., et al. (2011). Triterpenoids with neurotrophic activity from Ganoderma lucidum. Nat. Prod. Res. 25, 1607–1613. doi:10.1080/14786419.2010.496367
Zhao, L., Dong, Y., Chen, G., and Hu, Q. (2010). Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr. Polym. 80, 783–789. doi:10.1016/j.carbpol.2009.12.029
Zheng, S., Zhang, W., and Liu, S. (2020). Optimization of ultrasonic-assisted extraction of polysaccharides and triterpenoids from the medicinal mushroom Ganoderma lucidum and evaluation of their in vitro antioxidant capacities. PLOS ONE 15, e0244749. doi:10.1371/journal.pone.0244749
Zhu, M., Chang, Q., Wong, L. K., Chong, F. S., and Li, R. C. (1999). Triterpene antioxidants from Ganoderma lucidum. Phytother. Res. 13, 529–531. doi:10.1002/(sici)1099-1573(199909)13:6<529:aid-ptr481>3.0.co;2-x
Keywords: Ganoderma lucidum, bioactive function, active compounds, polysaccharides, triterpenoids
Citation: Cör Andrejč D, Knez Ž and Knez Marevci M (2022) Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. Front. Pharmacol. 13:934982. doi: 10.3389/fphar.2022.934982
Received: 03 May 2022; Accepted: 27 June 2022;
Published: 22 July 2022.
Edited by:
Sachchida Nand Rai, University of Allahabad, IndiaReviewed by:
Asgar Ali, University of Nottingham Malaysia Campus, MalaysiaDivya Mishra, University of Allahabad, India
Copyright © 2022 Cör Andrejč, Knez and Knez Marevci. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maša Knez Marevci, bWFzYS5rbmV6QHVtLnNp